SEC Form 4 · accession 0001127602-18-015508
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jo Ann Golden
Director
Period of report
Apr 27, 2018
Accepted (ET)
Apr 30, 2018 · 3:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2018 | M | 2,698 | $41.06 | A | 19,480 | D | |
| Common StockF1 | Apr 27, 2018 | S | 5,698 | $65.40 | D | 13,782 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF2 | $41.06 | Apr 27, 2018 | M | 2,698 | D | Jun 1, 2017 | Jun 1, 2026 | Common Stock | 2,698 | 2,698 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.19 to $65.53. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- F2The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.